Biological activities of lupeol in the management of chronic diseases

Lupeol is a common secondary metabolite found in over 200 plants. Lupeol is a pentacyclic triterpene of the lupane type found in many plants, fruits, and vegetables. Many traditional herbal treatments contain this chemical as their primary active ingredient. Because of their pharmacological properties against cancer, inflammation, arthritis, diabetes, and heart disease, lupeol and its analogs have been the subject of a significant number of publications during the last ten years. Numerous studies have shown that lupeol has a wide range of advantageous pharmacological properties, including anti-inflammatory, anti-hyperglycemic, anti-dyslipidemic, anti-mutagenic, and antioxidant properties. A thorough discussion of lupeol's biosynthesis, chemical makeup, and modes of action is provided, with a focus on how it affects signaling pathways like PI3K/Akt, NF-κB, and TLR4. This review attempts to give researchers the most recent information, highlight the limitations of pertinent research at this time, and highlight the areas that should be strengthened in future studies by summarizing the developments in pharmacological and pharmacokinetic studies of lupeol over the past ten years, with a focus on its anticancer and anti-inflammatory properties, as well as the research progress of lupeol derivatives thus far.

Authors

Publication Details

Journal
International Journal of Pharmaceutical Research and Development
Published
2025-01-01
DOI
https://doi.org/10.33545/26646862.2025.v7.i1c.110
Primary Topic
Natural product bioactivities and synthesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biological activities of lupeol in the management of chronic diseases

N Rizvi, Shivam Singh, Ashvani Kumar, Amresh Gupta
International Journal of Pharmaceutical Research and Development
Natural product bioactivities and synthesis
article

Biological activities of lupeol in the management of chronic diseases

N Rizvi, Shivam Singh, Ashvani Kumar, Amresh Gupta
article en

Abstract

Lupeol is a common secondary metabolite found in over 200 plants. Lupeol is a pentacyclic triterpene of the lupane type found in many plants, fruits, and vegetables. Many traditional herbal treatments contain this chemical as their primary active ingredient. Because of their pharmacological properties against cancer, inflammation, arthritis, diabetes, and heart disease, lupeol and its analogs have been the subject of a significant number of publications during the last ten years. Numerous studies have shown that lupeol has a wide range of advantageous pharmacological properties, including anti-inflammatory, anti-hyperglycemic, anti-dyslipidemic, anti-mutagenic, and antioxidant properties. A thorough discussion of lupeol's biosynthesis, chemical makeup, and modes of action is provided, with a focus on how it affects signaling pathways like PI3K/Akt, NF-κB, and TLR4. This review attempts to give researchers the most recent information, highlight the limitations of pertinent research at this time, and highlight the areas that should be strengthened in future studies by summarizing the developments in pharmacological and pharmacokinetic studies of lupeol over the past ten years, with a focus on its anticancer and anti-inflammatory properties, as well as the research progress of lupeol derivatives thus far.

International Journal of Pharmaceutical Research and DevelopmentVol. 7(1)
Zero hunger
Openalex Percentile: Top 94%
Natural product bioactivities and synthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.